drugset / Trial / NCT00326274

Clinical Safety Trial of Long-Term Intermittent Use of Helioblock® SX Cream

NCT00326274 ↗

Phase 3 Completed Loreal USA
Non-randomizedSingle-groupOpen-label

Summary

The purpose of this study is to determine the safety potential of Helioblock® SX Cream as a sunscreen product in long term intermittent use conditions among pediatric subjects.. Each subject will be enrolled to participate for six months. The test product should be applied every day that outdoor activities are planned, prior to any significant sun exposure during out-door activities (such as the beach, outdoor sport activities), or whenever the subject needs to be protected against sunburn or other damage due to the sun. A minimum of 14 days test product use and sun exposure is required.

Timeline

Start
2006-05
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Helioblock® SX Cream Unknown — Topical

Indications